1835 related articles for article (PubMed ID: 9153395)
1. Mdm2 promotes the rapid degradation of p53.
Haupt Y; Maya R; Kazaz A; Oren M
Nature; 1997 May; 387(6630):296-9. PubMed ID: 9153395
[TBL] [Abstract][Full Text] [Related]
2. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
3. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.
Li L; Liao J; Ruland J; Mak TW; Cohen SN
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1619-24. PubMed ID: 11172000
[TBL] [Abstract][Full Text] [Related]
4. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.
Böttger A; Böttger V; Sparks A; Liu WL; Howard SF; Lane DP
Curr Biol; 1997 Nov; 7(11):860-9. PubMed ID: 9382809
[TBL] [Abstract][Full Text] [Related]
5. c-Abl neutralizes the inhibitory effect of Mdm2 on p53.
Sionov RV; Moallem E; Berger M; Kazaz A; Gerlitz O; Ben-Neriah Y; Oren M; Haupt Y
J Biol Chem; 1999 Mar; 274(13):8371-4. PubMed ID: 10085066
[TBL] [Abstract][Full Text] [Related]
6. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.
Midgley CA; Lane DP
Oncogene; 1997 Sep; 15(10):1179-89. PubMed ID: 9294611
[TBL] [Abstract][Full Text] [Related]
7. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
Swaroop M; Sun Y
Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
Arriola EL; Lopez AR; Chresta CM
Oncogene; 1999 Jan; 18(4):1081-91. PubMed ID: 10023685
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar Arf sequesters Mdm2 and activates p53.
Weber JD; Taylor LJ; Roussel MF; Sherr CJ; Bar-Sagi D
Nat Cell Biol; 1999 May; 1(1):20-6. PubMed ID: 10559859
[TBL] [Abstract][Full Text] [Related]
10. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
11. Regulation of p53 stability by Mdm2.
Kubbutat MH; Jones SN; Vousden KH
Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
[TBL] [Abstract][Full Text] [Related]
12. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.
Yin Y; Stephen CW; Luciani MG; Fåhraeus R
Nat Cell Biol; 2002 Jun; 4(6):462-7. PubMed ID: 12032546
[TBL] [Abstract][Full Text] [Related]
13. MDM2 and MDMX bind and stabilize the p53-related protein p73.
Ongkeko WM; Wang XQ; Siu WY; Lau AW; Yamashita K; Harris AL; Cox LS; Poon RY
Curr Biol; 1999 Jul 29-Aug 12; 9(15):829-32. PubMed ID: 10469568
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.
Ard PG; Chatterjee C; Kunjibettu S; Adside LR; Gralinski LE; McMahon SB
Mol Cell Biol; 2002 Aug; 22(16):5650-61. PubMed ID: 12138177
[TBL] [Abstract][Full Text] [Related]
15. Induction of Mdm2 and enhancement of cell survival by bFGF.
Shaulian E; Resnitzky D; Shifman O; Blandino G; Amsterdam A; Yayon A; Oren M
Oncogene; 1997 Nov; 15(22):2717-25. PubMed ID: 9400998
[TBL] [Abstract][Full Text] [Related]
16. MdmX protects p53 from Mdm2-mediated degradation.
Jackson MW; Berberich SJ
Mol Cell Biol; 2000 Feb; 20(3):1001-7. PubMed ID: 10629057
[TBL] [Abstract][Full Text] [Related]
17. Hdmx and Mdm2 can repress transcription activation by p53 but not by p63.
Little NA; Jochemsen AG
Oncogene; 2001 Jul; 20(33):4576-80. PubMed ID: 11494153
[TBL] [Abstract][Full Text] [Related]
18. Interaction between the retinoblastoma protein and the oncoprotein MDM2.
Xiao ZX; Chen J; Levine AJ; Modjtahedi N; Xing J; Sellers WR; Livingston DM
Nature; 1995 Jun; 375(6533):694-8. PubMed ID: 7791904
[TBL] [Abstract][Full Text] [Related]
19. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.
Unger T; Juven-Gershon T; Moallem E; Berger M; Vogt Sionov R; Lozano G; Oren M; Haupt Y
EMBO J; 1999 Apr; 18(7):1805-14. PubMed ID: 10202144
[TBL] [Abstract][Full Text] [Related]
20. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
Li M; Brooks CL; Wu-Baer F; Chen D; Baer R; Gu W
Science; 2003 Dec; 302(5652):1972-5. PubMed ID: 14671306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
